US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 0.674
  • -0.086-11.37%
Close Dec 13 16:00 ET
  • 0.700
  • +0.026+3.86%
Post 20:01 ET
196.86MMarket Cap-0.85P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.02%-35.04M
2.72%-38.09M
9.08%-42.02M
3.46%-163.69M
-0.91%-40.64M
-1.57%-37.69M
11.67%-39.16M
3.43%-46.21M
-34.30%-169.56M
-21.24%-40.27M
Net income from continuing operations
12.33%-44.58M
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
Operating gains losses
-21.50%504K
--1.39M
---1.52M
186.08%1.51M
114.98%437K
-41.32%642K
----
----
-251.38%-1.75M
-789.60%-2.92M
Depreciation and amortization
-8.31%4.68M
-3.18%4.9M
-0.06%5.02M
12.38%20.25M
0.32%5.06M
10.45%5.1M
21.36%5.06M
20.06%5.03M
32.27%18.02M
10.43%5.04M
Other non cash items
77.89%-715K
-467.70%-2.14M
129.74%595K
30.38%-4.65M
--0
-262.35%-3.23M
-81.50%582K
50.77%-2M
-244.53%-6.68M
52.14%-7.76M
Change In working capital
-57.25%1.04M
-126.62%-954K
24.91%-3.24M
104.17%3.42M
103.97%1.72M
38.71%2.43M
109.44%3.58M
-80.45%-4.31M
-2,142.71%-82.02M
-1,299.36%-43.39M
-Change in prepaid assets
-143.22%-1.62M
-180.17%-841K
245.83%595K
258.79%3.13M
342.90%3.15M
2.50%-664K
158.37%1.05M
-2.77%-408K
71.83%-1.97M
-636.36%-1.3M
-Change in payables and accrued expense
-21.11%2.53M
-100.04%-1K
1.90%-3.72M
265.20%745K
-127.11%-1.31M
137.89%3.2M
204.54%2.65M
-9.69%-3.79M
-95.60%204K
12.30%4.85M
-Change in other current liabilities
212.50%126K
0.88%-112K
-0.89%-113K
-110.20%-449K
-107.94%-112K
-110.34%-112K
0.00%-113K
-105.54%-112K
-73.92%4.4M
-38.40%1.41M
-Change in other working capital
----
----
----
----
----
----
----
----
-705.61%-84.65M
-1,620.17%-48.35M
Cash from discontinued investing activities
Operating cash flow
7.02%-35.04M
2.72%-38.09M
9.08%-42.02M
3.46%-163.69M
-0.91%-40.64M
-1.57%-37.69M
11.67%-39.16M
3.43%-46.21M
-34.30%-169.56M
-21.24%-40.27M
Investing cash flow
Cash flow from continuing investing activities
-98.08%1.92M
-70.57%45.01M
-31.60%21.99M
1,694.87%184.05M
-315.85%-100.69M
274.60%99.67M
511.18%152.91M
223.09%32.15M
90.51%-11.54M
163.16%46.65M
Net PPE purchase and sale
69.74%-59K
64.52%-331K
98.04%-30K
88.94%-2.69M
99.45%-25K
93.01%-195K
86.99%-933K
84.25%-1.53M
62.94%-24.28M
55.38%-4.58M
Net investment purchase and sale
-98.02%1.98M
-70.53%45.34M
-34.62%22.02M
1,366.19%186.73M
-296.50%-100.67M
141.59%99.87M
26.26%153.85M
-57.79%33.69M
122.71%12.74M
108.49%51.23M
Cash from discontinued investing activities
Investing cash flow
-98.08%1.92M
-70.57%45.01M
-31.60%21.99M
1,694.87%184.05M
-315.85%-100.69M
274.60%99.67M
511.18%152.91M
223.09%32.15M
90.51%-11.54M
163.16%46.65M
Financing cash flow
Cash flow from continuing financing activities
0
-27.93%862K
139.13%27K
-83.61%1.74M
-12.05%759K
-103.00%-143K
-51.32%1.2M
-102.70%-69K
-97.35%10.64M
-88.34%863K
Net common stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--0
-30.82%862K
--103K
-80.17%2.2M
-7.84%882K
-98.60%72K
-49.29%1.25M
--0
17.52%11.1M
-87.07%957K
Net other financing activities
--0
--0
-10.14%-76K
0.87%-457K
-30.85%-123K
---215K
---50K
---69K
---461K
---94K
Cash from discontinued financing activities
Financing cash flow
--0
-27.93%862K
139.13%27K
-83.61%1.74M
-12.05%759K
-103.00%-143K
-51.32%1.2M
-102.70%-69K
-97.35%10.64M
-88.34%863K
Net cash flow
Beginning cash position
-40.48%133.71M
14.79%125.94M
17.84%145.93M
-57.92%123.83M
145.73%286.5M
9.05%224.65M
-50.78%109.71M
-57.92%123.83M
108.91%294.29M
-70.41%116.59M
Current changes in cash
-153.56%-33.12M
-93.24%7.78M
-41.54%-20M
112.96%22.1M
-2,040.45%-140.57M
169.15%61.84M
781.89%114.95M
80.22%-14.13M
-211.11%-170.46M
107.27%7.24M
End cash Position
-64.89%100.59M
-40.48%133.71M
14.79%125.94M
17.84%145.93M
17.84%145.93M
145.73%286.5M
9.05%224.65M
-50.78%109.71M
-57.92%123.83M
-57.92%123.83M
Free cash flow
7.34%-35.1M
4.16%-38.43M
11.94%-42.05M
14.16%-166.38M
9.34%-40.66M
5.05%-37.88M
22.15%-40.09M
17.09%-47.75M
-1.08%-193.83M
-3.15%-44.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.02%-35.04M2.72%-38.09M9.08%-42.02M3.46%-163.69M-0.91%-40.64M-1.57%-37.69M11.67%-39.16M3.43%-46.21M-34.30%-169.56M-21.24%-40.27M
Net income from continuing operations 12.33%-44.58M28.30%-45.81M9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M
Operating gains losses -21.50%504K--1.39M---1.52M186.08%1.51M114.98%437K-41.32%642K---------251.38%-1.75M-789.60%-2.92M
Depreciation and amortization -8.31%4.68M-3.18%4.9M-0.06%5.02M12.38%20.25M0.32%5.06M10.45%5.1M21.36%5.06M20.06%5.03M32.27%18.02M10.43%5.04M
Other non cash items 77.89%-715K-467.70%-2.14M129.74%595K30.38%-4.65M--0-262.35%-3.23M-81.50%582K50.77%-2M-244.53%-6.68M52.14%-7.76M
Change In working capital -57.25%1.04M-126.62%-954K24.91%-3.24M104.17%3.42M103.97%1.72M38.71%2.43M109.44%3.58M-80.45%-4.31M-2,142.71%-82.02M-1,299.36%-43.39M
-Change in prepaid assets -143.22%-1.62M-180.17%-841K245.83%595K258.79%3.13M342.90%3.15M2.50%-664K158.37%1.05M-2.77%-408K71.83%-1.97M-636.36%-1.3M
-Change in payables and accrued expense -21.11%2.53M-100.04%-1K1.90%-3.72M265.20%745K-127.11%-1.31M137.89%3.2M204.54%2.65M-9.69%-3.79M-95.60%204K12.30%4.85M
-Change in other current liabilities 212.50%126K0.88%-112K-0.89%-113K-110.20%-449K-107.94%-112K-110.34%-112K0.00%-113K-105.54%-112K-73.92%4.4M-38.40%1.41M
-Change in other working capital ---------------------------------705.61%-84.65M-1,620.17%-48.35M
Cash from discontinued investing activities
Operating cash flow 7.02%-35.04M2.72%-38.09M9.08%-42.02M3.46%-163.69M-0.91%-40.64M-1.57%-37.69M11.67%-39.16M3.43%-46.21M-34.30%-169.56M-21.24%-40.27M
Investing cash flow
Cash flow from continuing investing activities -98.08%1.92M-70.57%45.01M-31.60%21.99M1,694.87%184.05M-315.85%-100.69M274.60%99.67M511.18%152.91M223.09%32.15M90.51%-11.54M163.16%46.65M
Net PPE purchase and sale 69.74%-59K64.52%-331K98.04%-30K88.94%-2.69M99.45%-25K93.01%-195K86.99%-933K84.25%-1.53M62.94%-24.28M55.38%-4.58M
Net investment purchase and sale -98.02%1.98M-70.53%45.34M-34.62%22.02M1,366.19%186.73M-296.50%-100.67M141.59%99.87M26.26%153.85M-57.79%33.69M122.71%12.74M108.49%51.23M
Cash from discontinued investing activities
Investing cash flow -98.08%1.92M-70.57%45.01M-31.60%21.99M1,694.87%184.05M-315.85%-100.69M274.60%99.67M511.18%152.91M223.09%32.15M90.51%-11.54M163.16%46.65M
Financing cash flow
Cash flow from continuing financing activities 0-27.93%862K139.13%27K-83.61%1.74M-12.05%759K-103.00%-143K-51.32%1.2M-102.70%-69K-97.35%10.64M-88.34%863K
Net common stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees --0-30.82%862K--103K-80.17%2.2M-7.84%882K-98.60%72K-49.29%1.25M--017.52%11.1M-87.07%957K
Net other financing activities --0--0-10.14%-76K0.87%-457K-30.85%-123K---215K---50K---69K---461K---94K
Cash from discontinued financing activities
Financing cash flow --0-27.93%862K139.13%27K-83.61%1.74M-12.05%759K-103.00%-143K-51.32%1.2M-102.70%-69K-97.35%10.64M-88.34%863K
Net cash flow
Beginning cash position -40.48%133.71M14.79%125.94M17.84%145.93M-57.92%123.83M145.73%286.5M9.05%224.65M-50.78%109.71M-57.92%123.83M108.91%294.29M-70.41%116.59M
Current changes in cash -153.56%-33.12M-93.24%7.78M-41.54%-20M112.96%22.1M-2,040.45%-140.57M169.15%61.84M781.89%114.95M80.22%-14.13M-211.11%-170.46M107.27%7.24M
End cash Position -64.89%100.59M-40.48%133.71M14.79%125.94M17.84%145.93M17.84%145.93M145.73%286.5M9.05%224.65M-50.78%109.71M-57.92%123.83M-57.92%123.83M
Free cash flow 7.34%-35.1M4.16%-38.43M11.94%-42.05M14.16%-166.38M9.34%-40.66M5.05%-37.88M22.15%-40.09M17.09%-47.75M-1.08%-193.83M-3.15%-44.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List